{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:46:19Z","timestamp":1777956379302,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02287-2","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:16:23Z","timestamp":1773411383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT-based radiomics for differentiating low-grade and grade 3A of follicular lymphoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Jian","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingna","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"2287_CR1","doi-asserted-by":"crossref","unstructured":"Merryman R, Mehtap \u00d6, LaCasce A. Advancements in the management of follicular lymphoma: a comprehensive review. Turk J Haematol. 2024.","DOI":"10.4274\/tjh.galenos.2024.2024.0015"},{"issue":"20","key":"2287_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"1","key":"2287_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/asheducation-2016.1.277","volume":"2016","author":"N Fowler","year":"2016","unstructured":"Fowler N. Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy? Hematol Am Soc Hematol Educ Program. 2016;2016(1):277\u201383.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2287_CR4","doi-asserted-by":"crossref","unstructured":"Casulo C. How I manage patients with follicular lymphoma. Br J Haematol. 2019;186(4).","DOI":"10.1111\/bjh.16011"},{"issue":"12","key":"2287_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/ajh.26737","volume":"97","author":"E Jacobsen","year":"2022","unstructured":"Jacobsen E. Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol. 2022;97(12):1638\u201351.","journal-title":"Am J Hematol"},{"issue":"7","key":"2287_CR6","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","volume":"103","author":"H Horn","year":"2018","unstructured":"Horn H, Kohler C, Witzig R, Kreuz M, Leich E, Klapper W, et al. Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. Haematologica. 2018;103(7):1182\u201390.","journal-title":"Haematologica"},{"issue":"6","key":"2287_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s12185-016-2099-7","volume":"104","author":"B Mihaljevic","year":"2016","unstructured":"Mihaljevic B, Jelicic J, Andjelic B, Antic D, Markovic O, Petkovic I, et al. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. Int J Hematol. 2016;104(6):692\u20139.","journal-title":"Int J Hematol"},{"issue":"12","key":"2287_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/ajh.25973","volume":"95","author":"F Mir","year":"2020","unstructured":"Mir F, Mattiello F, Grigg A, Herold M, Hiddemann W, Marcus R, et al. Follicular lymphoma evaluation index (FLEX): a new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. Am J Hematol. 2020;95(12):1503\u201310.","journal-title":"Am J Hematol"},{"issue":"3","key":"2287_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","volume":"53","author":"L Zanoni","year":"2023","unstructured":"Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, et al. PET\/CT in non-Hodgkin lymphoma: an update. Semin Nucl Med. 2023;53(3):320\u201351.","journal-title":"Semin Nucl Med"},{"issue":"14","key":"2287_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","volume":"29","author":"BD Cheson","year":"2011","unstructured":"Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol. 2011;29(14):1844\u201354.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2287_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.blre.2016.02.003","volume":"30","author":"L Valls","year":"2016","unstructured":"Valls L, Badve C, Avril S, Herrmann K, Faulhaber P, O\u2019Donnell J, et al. FDG-PET imaging in hematological malignancies. Blood Rev. 2016;30(4):317\u201331.","journal-title":"Blood Rev"},{"issue":"12","key":"2287_CR12","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","volume":"37","author":"L Le Dortz","year":"2010","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y, et al. Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(12):2307\u201314.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2287_CR13","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","volume":"34","author":"M Meignan","year":"2016","unstructured":"Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, et al. Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies. J Clin Oncol. 2016;34:3618\u201326.","journal-title":"J Clin Oncol"},{"key":"2287_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00277-017-3154-z","volume":"97","author":"M Sorigu\u00e9","year":"2018","unstructured":"Sorigu\u00e9 M, Sancho J. Current prognostic and predictive factors in follicular lymphoma. Ann Hematol. 2018;97:209\u201327.","journal-title":"Ann Hematol"},{"issue":"11","key":"2287_CR15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.6004\/jnccn.2023.0057","volume":"21","author":"AD Zelenetz","year":"2023","unstructured":"Zelenetz AD, Gordon LI, Abramson JS, et al. NCCN Guidelines\u00ae Insights: B-cell lymphomas, version 6.2023. J Natl Compr Canc Netw. 2023;21(11):1118\u201331.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2287_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2020.263194","volume":"107","author":"C Rossi","year":"2022","unstructured":"Rossi C, Tosolini M, Gravelle P, Pericart S, Kanoun S, Evrard S, et al. Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. Haematologica. 2022;107(1):221\u201330.","journal-title":"Haematologica"},{"issue":"4","key":"2287_CR17","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.4143\/crt.2018.649","volume":"51","author":"JH Liang","year":"2019","unstructured":"Liang JH, Zhang YP, Xia J, Ding CY, Wu W, Wang L, et al. Prognostic value of baseline and interim total metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET-CT in patients with follicular lymphoma. Cancer Res Treat. 2019;51(4):1479\u201387.","journal-title":"Cancer Res Treat"},{"key":"2287_CR18","doi-asserted-by":"crossref","unstructured":"Li JW, Li SM. Radiomics in oncological PET\/CT: clinical applications. Nucl Med Mol Imaging. 2018;52(3).","DOI":"10.1007\/s13139-017-0500-y"},{"issue":"1","key":"2287_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s13139-019-00571-4","volume":"53","author":"S Ha","year":"2019","unstructured":"Ha S, Choi H, Paeng JC, Cheon GJ. Radiomics in oncological PET\/CT: a methodological overview. Nucl Med Mol Imaging. 2019;53(1):14\u201329.","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"2287_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"2","key":"2287_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/01617346231220000","volume":"46","author":"J Chen","year":"2024","unstructured":"Chen J, Wen Z, Yang X, Jia J, Zhang X, Pian L, Zhao P. Ultrasound-based radiomics for the classification of Henoch-Sch\u00f6nlein purpura nephritis in children. Ultrason Imaging. 2024;46(2):110\u201320.","journal-title":"Ultrason Imaging"},{"key":"2287_CR22","doi-asserted-by":"publisher","first-page":"108827","DOI":"10.1016\/j.compbiomed.2024.108827","volume":"179","author":"A Stefano","year":"2024","unstructured":"Stefano A. Challenges and limitations in applying radiomics to PET imaging: Possible opportunities and avenues for research. Comput Biol Med. 2024;179:108827.","journal-title":"Comput Biol Med"},{"issue":"6","key":"2287_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s12149-018-1260-1","volume":"32","author":"A Parvez","year":"2018","unstructured":"Parvez A, Tau N, Hussey D, Maganti M, Metser U. 18F-FDG PET\/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin\u2019s lymphoma as predictors of treatment outcome and survival. Ann Nucl Med. 2018;32(6):410\u201316.","journal-title":"Ann Nucl Med"},{"key":"2287_CR24","doi-asserted-by":"crossref","unstructured":"Ou X, Wang J, Zhou R, Zhu S, Pang F, Zhou Y, et al. Ability of 18F-FDG PET\/CT radiomic features to distinguish breast carcinoma from breast lymphoma. Contrast Media Mol Imaging. 2019.","DOI":"10.1155\/2019\/4507694"},{"key":"2287_CR25","doi-asserted-by":"crossref","unstructured":"Yang T, Sun Z, Shi Y, Teng Y, Cheng L, Zhu R, et al. Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients. Ann Hematol. 2024.","DOI":"10.1007\/s00277-024-06071-6"},{"issue":"5","key":"2287_CR26","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00259-021-05626-3","volume":"49","author":"FM de Jesus","year":"2022","unstructured":"de Jesus FM, Yin Y, Mantzorou-Kyriaki E, Kahle XU, de Haas RJ, Yakar D, et al. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F]FDG PET\/CT features. Eur J Nucl Med Mol Imaging. 2022;49(5):1535\u201343.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2287_CR27","doi-asserted-by":"crossref","unstructured":"Xu H, Guo W, Cui X, Zhuo H, Xiao Y, Ou X, et al. Three-dimensional texture analysis based on PET\/CT images to distinguish hepatocellular carcinoma and hepatic lymphoma. Front Oncol. 2019.","DOI":"10.3389\/fonc.2019.00844"},{"issue":"1","key":"2287_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12885-025-13507-3","volume":"25","author":"Z Wen","year":"2025","unstructured":"Wen Z, Gao X, Wu Q, Yang J, Sun J, Wu K, Zhao H, Wang R, Li Y. Baseline [18F]FDG PET\/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP. BMC Cancer. 2025;25(1):128.","journal-title":"BMC Cancer"},{"key":"2287_CR29","doi-asserted-by":"crossref","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78(16):4786\u20139.","DOI":"10.1158\/0008-5472.CAN-18-0125"},{"issue":"1","key":"2287_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clml.2019.09.609","volume":"20","author":"A Major","year":"2020","unstructured":"Major A, Hammes A, Schmidt MQ, Morgan R, Abbott D, Kamdar M. Evaluating novel PET-CT functional parameters TLG and TMTV in differentiating low-grade versus grade 3A follicular lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20(1):39\u201346.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"2287_CR31","first-page":"776","volume":"45","author":"T Zhao","year":"2024","unstructured":"Zhao T, Bai M, Wang R, Zhao M, Tian RR, Xing J, et al. Prognostic value and imaging features of 18F-FDG PET-CT in follicular lymphoma with different histopathology grade. Zhonghua Xue Ye Xue Za Zhi. 2024;45(8):776\u201380.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2287_CR32","doi-asserted-by":"crossref","unstructured":"Li H, Wang M, Zhang Y, Hu F, Wang K, Wang C, et al. Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET\/CT. Front Oncol. 2022.","DOI":"10.3389\/fonc.2022.943151"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02287-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02287-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02287-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:08:21Z","timestamp":1777946901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02287-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2287"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02287-2","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective study was approved by the Ethics Committee of Henan Cancer Hospital (No.2023-KY-0150-001) and was conducted in accordance with the Declaration of Helsinki. Informed consent was waived by Ethics Committee of Henan Cancer Hospital because of retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}